Vanguard Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,414,431
| Closed | -$602M | – | 4243 |
|
|
2020
Q3 | $602M | Sell |
4,414,431
-150,243
| -3% | -$16M | 0.02% | 698 |
|
|
2020
Q2 | $441M | Buy |
4,564,674
+532,583
| +13% | +$44.4M | 0.02% | 817 |
|
|
2020
Q1 | $189M | Buy |
4,032,091
+80,508
| +2% | +$5.16M | 0.01% | 1163 |
|
|
2019
Q4 | $288M | Buy |
3,951,583
+66,598
| +2% | +$4.04M | 0.01% | 1159 |
|
|
2019
Q3 | $203M | Buy |
3,884,985
+169,266
| +5% | +$9M | 0.01% | 1324 |
|
|
2019
Q2 | $186M | Buy |
3,715,719
+228,576
| +7% | +$11.1M | 0.01% | 1404 |
|
|
2019
Q1 | $181M | Buy |
3,487,143
+424,261
| +14% | +$19.5M | 0.01% | 1403 |
|
|
2018
Q4 | $150M | Buy |
3,062,882
+67,061
| +2% | +$3.69M | 0.01% | 1433 |
|
|
2018
Q3 | $195M | Buy |
2,995,821
+740,607
| +33% | +$43.6M | 0.01% | 1406 |
|
|
2018
Q2 | $112M | Buy |
2,255,214
+593,412
| +36% | +$28.7M | ﹤0.01% | 1714 |
|
|
2018
Q1 | $81.1M | Buy |
1,661,802
+637,519
| +62% | +$33.1M | ﹤0.01% | 1823 |
|
|
2017
Q4 | $43.1M | Buy |
1,024,283
+43,289
| +4% | +$1.67M | ﹤0.01% | 2134 |
|
|
2017
Q3 | $42M | Buy |
980,994
+216,075
| +28% | +$6.89M | ﹤0.01% | 2123 |
|
|
2017
Q2 | $10M | Buy |
764,919
+78,800
| +11% | +$1.04M | ﹤0.01% | 2768 |
|
|
2017
Q1 | $9.02M | Buy |
686,119
+55,927
| +9% | +$716K | ﹤0.01% | 2808 |
|
|
2016
Q4 | $8.16M | Buy |
630,192
+101,082
| +19% | +$1.56M | ﹤0.01% | 2830 |
|
|
2016
Q3 | $8.65M | Buy |
529,110
+214,310
| +68% | +$3.87M | ﹤0.01% | 2754 |
|
|
2016
Q2 | $3.9M | Buy |
314,800
+178,431
| +131% | +$2.23M | ﹤0.01% | 3093 |
|
|
2016
Q1 | $1.46M | Buy |
136,369
+77,511
| +132% | +$705K | ﹤0.01% | 3484 |
|
|
2015
Q4 | $863K | Buy |
+58,858
| New | +$720K | ﹤0.01% | 3670 |
|
Vanguard Group's MYOK Position: Q4 2020 in Review
Vanguard Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,414,431 shares — an estimated $602M sold.
Vanguard Group first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $602M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Vanguard Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Vanguard Group sold 4,414,431 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $602M.
- Vanguard Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Vanguard Group's MyoKardia, Inc. Common Stock position peaked at $602M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Vanguard Group's 13F filing for Q4 2020, filed 12 Feb 2021.